Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Oculogenex Logo
Oculogenex Growth Score
63
CB Rank
66876
Heat Score
54
Oculogenex is a biopharmaceutical company that specializes in gene therapy for the treatment of retinal disorders.
Founded
obfuscation
PrivateGrant La Habra, California, United States11-50 oculogenex.com
Biopharma
Biotechnology
Pharmaceutical
Overview

Oculogenex
Total Funding
obfuscation
Growth Score
63
Heat Score
54

Total Funding
obfuscation
obfuscation
Grant raised
obfuscation
Growth Score63
-3 pts
in past quarter
Heat Score 54
-13 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Oculogenex

CB Rank
66876
Oculogenex is a biopharmaceutical company that specializes in gene therapy for the treatment of retinal disorders.
Founded
obfuscation
PrivateGrant La Habra, California, United States11-50 oculogenex.com
Biopharma
Biotechnology
Pharmaceutical

Funding Rounds

Grant
OBF
in
obfuscation
Non-equity Assistance
OBF
in
obfuscation
Grant
OBF
in
obfuscation

Key People

Details

Legal Name Oculogenex
Operating Status Active
Company Type For Profit
Founders  Hema Ramkumar, Ram Ramkumar
About the Company
Oculogenex is a biopharmaceutical company that specializes in gene therapy for the treatment of retinal disorders. The company was founded in 2020 and is headquartered in La Habra, California.
Phone Number 562-726-4424
Contact Email info@oculogenex.com
Diversity Spotlight 
Women Founded
Women Led
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Investigational Gene Therapy for Dry Age-Related Macular Degeneration
A one-time intraocular injection gene therapy designed to stop the degeneration of central vision in patients with dry age-related macular degeneration by making retinal cells more resistant to stress, helping cells repair damage, and increasing their lifespan.

Research & Development

Oculogenex is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
...

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - Oculogenex Logo
Grant - Oculogenex
1
obfuscation
National Science FoundationGrant
obfuscation
Grant - Oculogenex Logo
Grant - Oculogenex
1
obfuscation
National Science FoundationGrant
obfuscation
Grant - Oculogenex Logo
Grant - Oculogenex
1
obfuscation
National Science FoundationGrant
obfuscation
Grant - Oculogenex Logo
Grant - Oculogenex
1
obfuscation
National Science FoundationGrant
obfuscation
Grant - Oculogenex Logo
Grant - Oculogenex
1
obfuscation
National Science FoundationGrant

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - Oculogenex Logo
Grant - Oculogenex
1
obfuscation
National Science FoundationGrant
obfuscation
Grant - Oculogenex Logo
Grant - Oculogenex
1
obfuscation
National Science FoundationGrant
obfuscation
Grant - Oculogenex Logo
Grant - Oculogenex
1
obfuscation
National Science FoundationGrant
obfuscation
Grant - Oculogenex Logo
Grant - Oculogenex
1
obfuscation
National Science FoundationGrant
obfuscation
Grant - Oculogenex Logo
Grant - Oculogenex
1
obfuscation
National Science FoundationGrant

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
National Science Foundation Logo
National Science Foundation
Yes
Grant - Oculogenex Logo
Grant - Oculogenex
—
National Science Foundation Logo
National Science Foundation
Yes
Grant - Oculogenex Logo
Grant - Oculogenex
—
National Science Foundation Logo
National Science Foundation
Yes
Grant - Oculogenex Logo
Grant - Oculogenex
—
National Science Foundation Logo
National Science Foundation
Yes
Grant - Oculogenex Logo
Grant - Oculogenex
—
National Science Foundation Logo
National Science Foundation
Yes
Grant - Oculogenex Logo
Grant - Oculogenex
—
Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 2 Contacts 2

Employee Profiles

News

News and Press

News•May 2, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 2, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jul 1, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 22, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

232

IT Spend

$113KThis year, Oculogenex is projected to spend $113K on IT, according to Aberdeen.

Active Website Tech Count

25Oculogenex is actively using 25 technologies for its website, according to BuiltWith. These include SPF, Google Font API, and  Apple Mobile Web Clips Icon.

Total IP

3The intellectual property of Oculogenex includes 3 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Oculogenex's headquarters? Oculogenex is located in La Habra, California, United States.Who invested in Oculogenex? Oculogenex has 2 investors including National Science Foundation and  MassChallenge.When was the last funding round for Oculogenex? Oculogenex closed its last funding round on
obfuscation
from a Grant round.Who are Oculogenex's competitors? Alternatives and possible competitors to Oculogenex may include Atsena Therapeutics, 4D Molecular Therapeutics, and  MeiraGTx.How much funding has Oculogenex raised to date? Oculogenex has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(bd7a319 1)
|